The Pharmacist Write Resources Hub

I Built a Crawler for BCBS Illinois Drug PA Policies. Here’s What I Found—and Why It Extends Beyond Illinois
I Built a Crawler for Cigna’s Drug PA Policies. Here’s What I Found
I Built a Crawler for Medica’s Drug PA Policies. Here’s What I Found—and Why It’s Bigger Than Medica
I Built a Crawler for UnitedHealthcare’s Drug PA Policies. Here’s What I Found
I Built a Crawler for Highmark’s Drug PA Policies. Here’s What I Found
Humira’s Denouement: The Biosimilar “Cliff” That Became a Slope
You Can Appeal Your Denial. You Can’t Appeal the Policy.
The Risk Your Health Plan Can’t See: How Discount Drug Cards Hide True Costs
Class Policy vs. Individual Drug Policy: Cystic Fibrosis Medications as a Case Example
When the Claim Clears, but Access Doesn’t
A Small Ambiguity in Drug Coverage Criteria
The Employer’s Guide to PBMs & Drug Coverage
Beyond the PDF: Why We Need a “Compositional Grammar” for Coverage Rules
The 90% Problem: Why GenAI Alone Can’t Solve Prior Authorization
Policy Vault: from PDFs and Portals to FHIR‑Ready Coverage Rules
Part 9: Bonus — Underwriting Transparent Drug Coverage
Part 8: The Fall of Rebates and the Rise of NodeID — Toward Transparent, Fixed-Gain Drug Access
Sunset Strategy: How Amgen’s Repatha Shows the Future of Late-Stage Asset Pharma Pricing
How Pharmacy Payers Change Policy: A Process Overview
What a Simple Drug Prior Authorization Policy Looks Like
Designing a Value-Based Formulary in 10 Steps
Pharmacy Benefit Management Consulting: What You Need to Know
Knockout Gene-Inspired Prior Authorization Logic
How Pharmacy Benefit Analytics Improves Plan Efficiency & Cost Management
Drug Utilization Management 101: Rules, Tools & Best Practices
Part 7: Gradual Governance Transfer – Shifting from Centralized PBMs to a Distributed, Multi-Stakeholder Model
Part 6: Applying Elinor Ostrom’s Framework – How Institutional Diversity Shapes Drug Coverage Node Enumeration
Part 5: Drug-Coverage Node Enumeration: Real-World Applications, Pilot Opportunities, and Future Outlook
Part 4: Building an Open Infrastructure for Node-Based Drug Coverage
Part 3: Building the Exhaustive Parameter Library: Enumerating All Coverage Options
Part 2: Introducing Enumerated Node-Based Drug Coverage: Redefining the Manufacturer–Payer Interface in Pharmacy Benefits
Part 1: The Origins of Drug Coverage Centralization – Why a New Model Is Needed
An Insurer-Less Pharmacy Ecosystem?
From P&T Committee to Exchange Forum: The Evolution of Drug Coverage Decision-Making
Reimagining The Claims Processing Partnership Structure: How Outsourcing Powers a Next-Gen PBM Alternative
Transparent Admin Fee vs. Spread Pricing: A Better Revenue Model for Pharmacy Services
Facing Manufacturer ‘Retribution’ Fears: How to Create a Safe Harbor for Direct Payer Deals
Decoupling Risk-Bearing from Pharmacy Benefits Managers: A Brief Overview for Self-Funded Employers
Formulary Contracting Exchanges: Bridging Manufacturers, Employers, and Insurers
P&T as a Service (P&TaaS): Bringing Clinical and Financial Clarity to Employers
Pharmacy Residencies: Advancing Your Career Path
Pharmacists’ Role in Managing Drug Shortages
Pharmacy Technician Certification: Steps to Success
Ambulatory Care Pharmacy: Expanding the Pharmacist’s Role
Medication Therapy Management (MTM): Beyond Traditional Pharmacy Practice
Building a Successful Managed Care Pharmacy Practice: Key Principles and Strategies
Specialty Pharmacy Services: Managing High-Cost Medications Effectively
Collaborating with Adjacent Stakeholders: Expanding the Pharmacist’s Impact
Telepharmacy and Beyond: The Digital Transformation of Medication Counseling
Understanding Pharmacy Benefit Managers: What Every Pharmacist Should Know